March 18, 2025 11:46am
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its … Continue reading
March 18, 2025 9:00am
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has confirmed a major milestone in quantum computing, demonstrating quantum computational supremacy on a practical, real-world problem. A newly published, peer-reviewed paper in Science validates … Continue reading
March 17, 2025 9:05am
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and contract development and manufacturing (CDMO) services, announced its participation in the BIO-Europe Spring 2025 conference from March 17-19 in Milan, Italy. The company’s leadership … Continue reading
March 14, 2025 9:45am
Social media marketing has grown exponentially since the turn of the century, when some 25 million social media identities existed worldwide. Last year’s Digital 2024: Global Overview Report by DataReportal (https://ibn.fm/zfypb) found that there were now well over 5 billion … Continue reading
March 14, 2025 8:30am
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced its financial results for fourth quarter and year-end 2024, with a 128% year-over-year increase in bookings, reaching $23.9 million in bookings for the … Continue reading
March 13, 2025 1:38pm
Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is set to benefit from a projected rise in palladium prices, which one industry analyst predicts could double over the next decade. The expected surge is attributed to several key factors including supply … Continue reading
March 13, 2025 9:45am
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while … Continue reading
March 12, 2025 9:00am
Clene Inc. (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), will attend … Continue reading
March 11, 2025 9:20am
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) announced further assay results from its definition diamond drilling program at the Iska Iska silver-tin polymetallic project in Bolivia, highlighting the highest-grade silver intersection recorded in the program. Hole DSB-75 returned 135 … Continue reading
March 11, 2025 9:00am
Newton Golf (Nasdaq: SPGC), formerly Sacks Parente Golf, has officially changed its corporate name to better align with its commitment to golf technology innovation. The rebranding reflects the company’s focus on advanced physics and precision engineering in golf equipment. Additionally, … Continue reading
March 07, 2025 3:36pm
Domestic manufacturing of goods has become increasingly advantageous for companies aiming to enhance quality control, reduce lead times and navigate complex international trade dynamics, with recent tariff announcements making this even more compelling. “Massimo Group (NASDAQ: MAMO), a prominent player … Continue reading
March 07, 2025 2:47pm
Thumzup (NASDAQ: TZUP) is democratizing the $200 billion social media advertising industry with an increasingly popular platform designed to connect small-business advertisers directly with everyday social media users. “The innovative approach has already attracted a growing list of customers… Thumzup leverages … Continue reading
March 07, 2025 1:33pm
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., is partnering with APST Research GmbH to analyze neurofilament light chain (“NfL”) data in evaluating its drug candidate, CNM-Au8®, for ALS treatment. Based in Germany, APST operates one of the … Continue reading
March 07, 2025 10:45am
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, and the first supplier of production-grade quantum computers, and Staque, a leading consulting and development practice in AI, blockchain and quantum computing, collaborated to develop … Continue reading
March 06, 2025 10:45am
The palladium market may be poised for a transformation over the next decade, with one industry analyst forecasting a price increase. The anticipated higher price would present a promising opportunity for companies deeply invested in palladium, such as Platinum Group Metals … Continue reading
March 06, 2025 10:10am
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced it will release its financial results for the full-year ended Dec. 31, 2024, before market open on March 17, 2025. Executive Chairman and CEO Charles M. Fernandez, CFO Cecile Munnik, and … Continue reading
March 06, 2025 10:00am
In the ever-evolving landscape of golf equipment, Newton Golf (NASDAQ: SPGC) has emerged as a beacon of innovation and quality. Formerly operating under the name Sacks Parente Golf, the company underwent a strategic rebranding to align more closely with its … Continue reading
March 06, 2025 8:55am
Clene (NASDAQ: CLNN) a late clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and MS, announced its participation in the 37th Annual Roth Conference. Management will host a virtual fireside chat on March 18, 2025, at 9:20 a.m. … Continue reading